Stassen HH, Bachmann S, Bridler R, Cattapan K, Herzig D, Schneeberger A, Seifritz E (2022) Detailing the effects of Polypharmacy in Psychiatry: longitudinal study of 320 patients hospitalized for Depression or Schizophrenia. Eur Arch Psychiatry Clin Neurosci 272(4):603–619. https://doi.org/10.1007/s00406-021-01358-5
Article PubMed CAS Google Scholar
Huhn M, Nikolakopoulou A, Schneider-Thoma J, Krause M, Samara M, Peter N, Arndt T, Bäckers L, Rothe P, Cipriani A, Davis J, Salanti G, Leucht S (2019) Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet 394(10202):939–951. https://doi.org/10.1016/S0140-6736(19)31135-3
Article PubMed PubMed Central CAS Google Scholar
Santarsieri D, Schwartz TL (2015) Antidepressant efficacy and side effect burden: a quick guide for clinicians. Drugs Context 4:212290. https://doi.org/10.7573/dic.212290
Article PubMed PubMed Central Google Scholar
Carvalho AF, Sharma MS, Brunoni AR, Vieta E, Fava GA (2016) The Safety, Tolerability and Risks Associated with the use of newer generation antidepressant drugs: a critical review of the literature. Psychother Psychosom 85(5):270–288. https://doi.org/10.1159/000447034
Stroup TS, Gray N (2018) Management of common adverse effects of antipsychotic medications. World Psychiatry 17(3):341–356. https://doi.org/10.1002/wps.20567
Article PubMed PubMed Central Google Scholar
Braund TA, Tillman G, Palmer DM, Gordon E, Rush AJ, Harris AWF (2021) Antidepressant side effects and their impact on treatment outcome in people with major depressive disorder: an iSPOT-D report. Transl Psychiatry 11(1):417. https://doi.org/10.1038/s41398-021-01533-1
Article PubMed PubMed Central CAS Google Scholar
Dye L, Boyle NB, Champ C, Lawton C (2017) The relationship between obesity and cognitive health and decline. Proc Nutr Soc 76(4):443–454
Alonso-Pedrero L, Bes-Rastrollo M, Marti A (2019) Effects of antidepressant and antipsychotic use on weight gain: a systematic review. Obes Rev 20(12):1680–1690. https://doi.org/10.1111/obr.12934
Milaneschi Y, Simmons WK, van Rossum EFC, Penninx BW (2019) Depression and obesity: evidence of shared biological mechanisms. Mol Psychiatry 24(1):18–33
Article PubMed CAS Google Scholar
Stassen HH, Bachmann S, Bridler R, Cattapan K, Seifritz E (2024) Polypharmacy in psychiatry and weight gain: longitudinal study of 832 patients hospitalized for depression or schizophrenia, along with data of 3,180 students from Europe, the U.S., South America, and China. Eur Arch Psychiatry Clin Neurosci (Epub ahead of print) https://doi.org/10.1007/s00406-024-01767-2
Allen JD, Bishop JR (2019) A systematic review of genome-wide association studies of antipsychotic response. Pharmacogenomics 20(4):291–306. https://doi.org/10.2217/pgs-2018-0163
Article PubMed PubMed Central CAS Google Scholar
Howard DM et al (2019) Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat Neurosci 22(3):343–352. https://doi.org/10.1038/s41593-018-0326-7
Article PubMed PubMed Central CAS Google Scholar
Trubetskoy V et al (2022) Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature 604(7906):502–508. https://doi.org/10.1038/s41586-022-04434-5
Article PubMed PubMed Central CAS Google Scholar
Li M, Li T, Xiao X, Chen J, Hu Z, Fang Y (2022) Phenotypes, mechanisms and therapeutics: insights from bipolar disorder GWAS findings. Mol Psychiatry 27(7):2927–2939. https://doi.org/10.1038/s41380-022-01523-9
Andrews SJ, Fulton-Howard B, Goate A (2020) Interpretation of risk loci from genome-wide association studies of Alzheimer’s disease. Lancet Neurol 19(4):326–335. https://doi.org/10.1016/S1474-4422(19)30435-1
Article PubMed PubMed Central Google Scholar
Greenwood TA, Lazzeroni LC, Calkins ME, Freedman R, Green MF, Gur RE, Gur RC, Light GA, Nuechterlein KH, Olincy A, Radant AD, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Sugar CA, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL (2016) Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study. Schizophr Res 170(1):30–40. https://doi.org/10.1016/j.schres.2015.11.008
Dattani S, Howard DM, Lewis CM, Sham PC (2022) Clarifying the causes of consistent and inconsistent findings in genetics. Genet Epidemiol 46(7):372–389. https://doi.org/10.1002/gepi.22459
Article PubMed PubMed Central CAS Google Scholar
Chua EHZ, Yasar S, Harmston N (2022) The importance of considering regulatory domains in genome-wide analyses - the nearest gene is often wrong! Biol Open 11(4):bio059091. https://doi.org/10.1242/bio.059091
Article PubMed PubMed Central CAS Google Scholar
Stassen HH, Bachmann S, Bridler R, Cattapan K, Hartmann AM, Rujescu D, Seifritz E, Weisbrod M, Scharfetter C (2024) Analysis of genetic diversity in patients with major psychiatric disorders versus healthy controls: a molecular-genetic study of 1698 subjects genotyped for 100 candidate genes (549 SNPs). Psychiatry Res 333:115720. https://doi.org/10.1016/j.psychres.2024.115720(Epub ahead of print)
Article PubMed CAS Google Scholar
Myung W, Kim J, Lim SW, Shim S, Won HH, Kim S, Kim S, Lee MS, Chang HS, Kim JW, Carroll BJ, Kim DK (2015) A genome-wide association study of antidepressant response in koreans. Transl Psychiatry 5(9):e633. https://doi.org/10.1038/tp.2015.127. Erratum in: Transl Psychiatry. 2015; 5:e672
Article PubMed PubMed Central CAS Google Scholar
Koromina M, Koutsilieri S, Patrinos GP (2020) Delineating significant genome-wide associations of variants with antipsychotic and antidepressant treatment response: implications for clinical pharmacogenomics. Hum Genomics 14(1):4. https://doi.org/10.1186/s40246-019-0254-y
Article PubMed PubMed Central CAS Google Scholar
Li QS, Tian C, Hinds D, 23andMe Research Team (2020) Genome-wide association studies of antidepressant class response and treatment-resistant depression. Transl Psychiatry 10(1):360. https://doi.org/10.1038/s41398-020-01035-6
Article PubMed PubMed Central CAS Google Scholar
Wigmore EM, Hafferty JD, Hall LS, Howard DM, Clarke TK, Fabbri C, Lewis CM, Uher R, Navrady LB, Adams MJ, Zeng Y, Campbell A, Gibson J, Thomson PA, Hayward C, Smith BH, Hocking LJ, Padmanabhan S, Deary IJ, Porteous DJ, Mors O, Mattheisen M, Nicodemus KK, McIntosh AM (2020) Genome-wide association study of antidepressant treatment resistance in a population-based cohort using health service prescription data and meta-analysis with GENDEP. Pharmacogenomics J 20(2):329–341. https://doi.org/10.1038/s41397-019-0067-3
Article PubMed CAS Google Scholar
Marshe VS, Maciukiewicz M, Hauschild AC, Islam F, Qin L, Tiwari AK, Sibille E, Blumberger DM, Karp JF, Flint AJ, Turecki G, Lam RW, Milev RV, Frey BN, Rotzinger S, Foster JA, Kennedy SH, Kennedy JL, Mulsant BH, Reynolds CF 3rd, Lenze EJ, Müller DJ (2021) Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant response. Transl Psychiatry 11(1):127. https://doi.org/10.1038/s41398-021-01248-3
Article PubMed PubMed Central CAS Google Scholar
Lu Z, Zhang Y, Yan H, Su Y, Guo L, Liao Y, Lu T, Yu H, Wang L, Li J, Li W, Yang Y, Xiao X, Lv L, Tan Y, Zhang D, Yue W (2022) ATAD3B and SKIL polymorphisms associated with antipsychotic-induced QTc interval change in patients with schizophrenia: a genome-wide association study. Transl Psychiatry 12(1):56. https://doi.org/10.1038/s41398-022-01825-0
Article PubMed PubMed Central CAS Google Scholar
Zhao M, Ma J, Li M, Zhu W, Zhou W, Shen L, Wu H, Zhang N, Wu S, Fu C, Li X, Yang K, Tang T, Shen R, He L, Huai C, Qin S (2022) Different responses to risperidone treatment in Schizophrenia: a multicenter genome-wide association and whole exome sequencing joint study. Transl Psychiatry 12(1):173. https://doi.org/10.1038/s41398-022-01942-w
留言 (0)